Study Links SRT1720 to Reduced Depressive-Like Behaviors and Enhanced Parkin-Mediated Mitophagy in LPS-Treated Mice

A recent study published in *BMC Neuroscience* has identified a potential link between mitophagy, specifically Parkin-mediated processes, and depressive-like behaviors in mice induced by lipopolysaccharides (LPS). Researchers Sun, L., Li, C., and Shi, J. conducted experiments to investigate the effects of SRT1720, a compound known for its role in activating sirtuin 1 (SIRT1), on depression-related behaviors and cellular mechanisms. Their findings indicate that SRT1720 alleviates depressive-like symptoms in murine models while simultaneously enhancing Parkin-mediated mitophagy.

The study focused on the impact of LPS-induced inflammation on mood-related behaviors and mitochondrial function. Researchers observed that treatment with SRT1720 reduced depressive-like behaviors in mice exposed to LPS. Additionally, they reported increased activation of Parkin-mediated mitophagy—a process where damaged mitochondria are selectively degraded—following administration of the compound. These results suggest a connection between improved mitochondrial quality control and behavioral improvements in the tested animals. The research provides further insight into how targeting cellular processes such as mitophagy may influence mood regulation under inflammatory conditions.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: November 30, 2025

Related posts:

Biologic Drug Patents Require Tailored Approach Addressing Structure, Function, and Manufacturing. FDA Initiative Targets Challenges in Rare Disease Research Amid Concerns Over Policy Changes Study Reveals Role of Botryosphaeria dothidea Metabolites in Enhancing Agarwood Production from Aquilaria sinensis FDA Clears Dexcom Smart Basal System with 15-Day CGM Sensor for Optimized Type 2 Diabetes Insulin Dosing

Author

GOAI